Details for Luxembourg Supplementary Protection Certificate: 93081
✉ Email this page to a colleague
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2101777 | 93081 | Luxembourg | PRODUCT NAME: AMBRISENTAN UTILISE EN TRAITEMENT COMBINE AVEC TADALAFIL; FRIST REGISTRATION: 20151125 | ⤷ Try a Trial |